UBS analyst Eliana Merle lowered the firm’s price target on Apellis (APLS) to $45 from $74 and keeps a Buy rating on the shares. The firm says the company’s Q3 resent expectatoins.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.